Skip to content
HowShorted

ASSEMBLY BIOSCIENCES, INC. short interest in 2025

In 2025, ASSEMBLY BIOSCIENCES, INC.'s disclosed short interest ran from 0.23% of shares outstanding on 15 Jan 2025 to 9.76% on 31 Dec 2025, a change of +9.53 percentage points. The year's high was 20.00% on 15 Oct 2025 and its low 0.18% on 30 Apr 2025, averaging 5.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.45 days on 15 Dec 2025. Full history: ASSEMBLY BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ASSEMBLY BIOSCIENCES, INC. in 2025

2025 in figures

Start of year
0.23% (15 Jan 2025)
End of year
9.76% (31 Dec 2025)
Change
+9.53 pp
High
20.00% (15 Oct 2025)
Low
0.18% (30 Apr 2025)
Average
5.25%
Highest days to cover
13.45 (15 Dec 2025)
SEC filings marked
8

Every report in 2025

ASSEMBLY BIOSCIENCES, INC. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20250.23%1.00
31 Jan 20250.22%1.00
14 Feb 20250.27%1.00
28 Feb 20250.32%1.00
14 Mar 20250.28%1.02
31 Mar 20250.23%1.0010-K filed, results (8-K)
15 Apr 20250.25%1.00
30 Apr 20250.18%1.13
15 May 20250.35%1.1510-Q filed, results (8-K)
30 May 20250.19%1.11
13 Jun 20250.22%1.00
30 Jun 20250.41%1.00
15 Jul 20250.41%1.00
31 Jul 20250.39%1.20
15 Aug 20256.92%3.6410-Q filed, results (8-K)
29 Aug 202511.88%6.00
15 Sep 202513.90%7.74
30 Sep 202517.63%7.10
15 Oct 202520.00%10.64
31 Oct 202516.81%10.42
14 Nov 20258.26%9.3210-Q filed, results (8-K)
28 Nov 20258.15%10.09
15 Dec 20258.63%13.45
31 Dec 20259.76%8.60

See also: ASSEMBLY BIOSCIENCES, INC.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.